Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Prostatic Neoplasms 2Wilms Tumor 1Sarcoma 1Prostatic Intraepithelial Neoplasia 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 6fludarabine phosphate 4Flow Cytometry 4Antilymphocyte Serum 4Tacrolimus 3Psychiatric Rehabilitation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Filgrastim 3Busulfan 3Azacitidine 3Alemtuzumab 3Vincristine 2Radiotherapy 2Polymerase Chain Reaction 2Methylprednisolone 2Methotrexate 2Immunologic Techniques 2Gene Expression Profiling 2Cyclosporine 2Counseling 2Bupropion 2Blood Specimen Collection 2thymoglobulin 1tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1pembrolizumab 1motexafin gadolinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Dietary Supplements × Genitourinary × Clear all
NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Columbia University

Phase 2 Completed
56 enrolled 5 charts
GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡